Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SHR-A2102
i
Other names:
SHR-A2102, SHRA2102, SHR A2102
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Jiangsu Hengrui Pharma
Drug class:
Nectin-4-targeted antibody-drug conjugate
Related drugs:
‹
enfortumab vedotin-ejfv (14)
9MW2821 (1)
SBT6290 (1)
BAT8007 (0)
Nectin-4 ADC (0)
SKB410 (0)
enfortumab vedotin-ejfv (14)
9MW2821 (1)
SBT6290 (1)
BAT8007 (0)
Nectin-4 ADC (0)
SKB410 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Urothelial Cancer
No biomarker
Urothelial Cancer
SHR-A2102
Sensitive: B - Late Trials
SHR-A2102
Sensitive
:
B
SHR-A2102
Sensitive: B - Late Trials
SHR-A2102
Sensitive
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login